Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image

NEW POLIO VACCINE

High Immunity Rate Predicted LONDON, December 4. A more potent and safer form of Salk anti-polio vaccine is being developed in Britain to give nearly 100 per cent, immunity to everyone who has three injections. The new vaccine could be mixed with' others in a four-in-one “cocktail” to protect children against diseases such as diphtheria and whooping cough, said the “Daily Mail.” Three British firms are working on the improved vaccine. A version of it has already been brought out in America. The new vaccine, which might be produced next year, would mean that immunity could be lifted from the present 70 per cent, to at least 90 per cent., the newspaper said. Allergic side-effects in some persons would be eliminated and the time which protection lasted could be extended with very few injections. Doctors predicted that the new Salk vaccine would make polio as rare in the next five years as diphtheria was today, the “Daily Mail” added.

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/CHP19601206.2.127

Bibliographic details

Press, Volume XCIX, Issue 29380, 6 December 1960, Page 17

Word Count
162

NEW POLIO VACCINE Press, Volume XCIX, Issue 29380, 6 December 1960, Page 17

NEW POLIO VACCINE Press, Volume XCIX, Issue 29380, 6 December 1960, Page 17

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert